Kevin Eisenfrats is the Co-Founder and CEO of Contraline, a clinical-stage biotechnology company developing the worlds first reversible male contraceptive. An inventor on over 50 patents, he has raised over $30 million from investors like GV and Founders Fund. He earned his degree in Nanomedicine Engineering from the University of Virginia.
Kevins interest in reproductive health was sparked during his teenage years by the MTV show "16 and Pregnant, " which inspired his career path. He is also an angel investor with a focus on biotech, womens health, and deep tech companies, demonstrating a deep commitment to advancing healthcare innovation beyond his primary role.
He has been named to both Forbes 30 Under 30 and MIT Technology Reviews 35 Innovators Under 35.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.